Hostname: page-component-cd9895bd7-mkpzs Total loading time: 0 Render date: 2024-12-25T04:25:49.412Z Has data issue: false hasContentIssue false
  • English
  • Français

Coverage and Reimbursement for Heart Transplantation

Published online by Cambridge University Press:  10 March 2009

Roger W. Evans
Roger W. Evans
Affiliation:
Battelle Human Affairs Research Centers
Get access Rights & Permissions [Opens in a new window]

Extract

From the perspectives of coverage and reimbursement, heart transplantation has been a serious concern of policymakers in the U.S. since 1980, the year it was decided that a comprehensive study was required before the Health Care Financing Administration (HCFA), the federal agency responsible for the administration of the Medicare program, would be able to decide the status of the procedure (14;15;30;35). It was well acknowledged that the issues surrounding this decision were complex and that initial attempts to resolve the underlying coverage issue seemed to be too narrowly construed. It was at this time that the late Patricia Roberts Harris, then Secretary of the Department of Health and Human Services (DHHS), declared that DHHS would require new technologies to pass muster on the basis of their “social consequences” before “financing their wide distribution” (30). In a very special sense, although not appreciated at the time, a new era of health care technology assessment was ushered in, as Harris proclaimed that the then-conceived study of heart transplantation should serve as the “prototype” of technology assessment.

Type
Special Section: Transplantation and Artificial Organs
Information
International Journal of Technology Assessment in Health Care , Volume 2 , Issue 3 , July 1986 , pp. 425 - 449
Copyright
Copyright © Cambridge University Press 1986

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Banta, H. D., Behney, C. J., & Willems, J. S.Toward rational technology in medicine. New York, NY: Springer, 1981.Google ScholarPubMed
2.Bazzoli, G. J.Health care for the indigent: Literature review and research agenda for the future. AHA Council report. Chicago, IL: American Hospital Association, 1985.Google Scholar
3.Blendon, R. J. & Altman, D. E.Public attitudes about health care costs: A lesson in national schizophrenia. New England Journal of Medicine, 1984, 311, 613–16.CrossRefGoogle ScholarPubMed
4.Bunker, J. P., Fowles, J., & Schaffarzick, R.Evaluation of medical-technology strategies: Effects of coverage and reimbursement (first of two parts). New England Journal of Medicine, 1982, 306, 620–24.CrossRefGoogle ScholarPubMed
5.Caplan, A. L.Ethical and policy issues in the procurement of cadaver organs for transplantation. New England Journal of Medicine, 1984, 311, 981–83.CrossRefGoogle ScholarPubMed
6.The EC/IC Bypass Study Group. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke: Results of an international randomized trial. New England Journal of Medicine, 1985, 313, 1191–200.CrossRefGoogle Scholar
7.Evans, R. W. The heart transplant dilemma. Issues in Science and Technology, in press.Google Scholar
8.Evans, R. W.The socioeconomics of organ transplantation. Transplantation Proceedings, 1985, 17, Suppl. 4. 129–36.Google ScholarPubMed
9.Evans, R. W.The proliferation of cardiac transplant facilities: Results of a survey of hospitals with open heart surgery facilities. Seattle, WA: Battelle Human Affairs Research Centers, 1985.Google Scholar
10.Evans, R. W.A response to the Public Health Service's review of the Final Report for the National Heart Transplantation Study. Transmitted to the Health Care Financing Administration. Seattle, WA: Battelle Human Affairs Research Centers, 1985.Google Scholar
11.Evans, R. W. Experiment versus therapy: Is the dilemma worth the debate? In Evans, R. W., Manninen, D. L., Overcast, T. D. et al. , The National Heart Transplantation Study: final report. Seattle, WA: Battelle Human Affairs Research Centers, 1984, 42–1–42–41.Google Scholar
12.Evans, R. W. Lessons learned from the end-stage renal disease experience: their implications for heart transplantation. In Evans, R. W., Manninen, D. L., Overcast, T. D. et al. , The National Heart Transplantation Study: final report. Seattle, WA: Battelle Human Affairs Research Centers, 1984, 44–1–44–43.Google Scholar
13.Evans, R. W. Sources of payment for heart transplantation with an emphasis on the role of private insurance. In Evans, R. W., Manninen, D. L., Overcast, T. D. et al. , The National Heart Transplantation Study: final report. Seattle, WA: Battelle Human Affairs Research Centers, 1984, 40–1–40–31.Google Scholar
14.Evans, R. W.Organ transplantation. Science, 1983, 222, 234.Google ScholarPubMed
15.Evans, R. W., Anderson, A., & Perry, B.An overview of the National Heart Transplantation Study. Heart Transplantation, 1982, 2, 85–87.Google Scholar
16.Evans, R. W., Manninen, D. L., Gersh, B. J., Hart, L. G., & Rodin, J.The need for and supply of donor hearts for transplantation. Heart Transplantation, 1984, 4, 57–62.Google Scholar
17.Evans, R. W., Manninen, D. L., Overcast, T. D., et al. The National Heart Transplantation Study: final report. Volumes 1–5. Seattle, WA: Battelle Human Affairs Research Centers, 1984.Google Scholar
18.Evans, R. W., Manninen, D. L., Overcast, T. L., Garrison, L. P. Jr, & Maier., A. Donor availability as the primary determinant of the future of heart transplantation. Journal of the American Medical Association, in press.Google Scholar
19.Frommer, P. L. December 7, 1979 memorandum to Director, National Center for Health Care Technology. Subject: Medicare coverage for heart transplants. Bethesda, MD: National Heart, Lung, and Blood Institute, 1979.Google Scholar
20.Frommer, P. L. January 21, 1980 memorandum to Director, Coverage Assessment Staff, National Center for Health Care Technology. Subject: Medicare coverage of heart transplants. Bethesda, MD: National Heart, Lung, and Blood Institute, 1980.Google Scholar
21.Haddow, C. Mc. October 9, 1985 memorandum to The Secretary. Subject: Heart transplantation decision memorandum and report—action. Washington, DC: Health Care Financing Administration, 1985.Google Scholar
22.Health Insurance Association of America. Organ transplants and their implications for the health insurance industry. Washington, DC: Public Relations Division, HIAA, 1985.Google Scholar
23.Health Insurance Association of America. Testimony before the Subcommittee on Health of the Committee on Finance U.S. Senate, April 27, 1984. Cited from Senate Committee on Finance, “Health Care to the Economically Disadvantaged,” September 1984.Google Scholar
24.Heckler, M. M. Statement read on May 2, 1985. Washington, DC: Department of Health and Human Services, 1985.Google Scholar
25.Hellinger, F. J.An analysis of a public program for heart transplantation. Journal of Human Resources. 1982, 17, 307–13.CrossRefGoogle ScholarPubMed
26.Intergovernmental Health Policy Project. Medicaid coverage and payment policies for organ transplants: A fifty state review. Washington, DC: George Washington University, 1985.Google Scholar
27.Jackson, D. L.Ohio's plan for organ transplantation. New England Journal of Medicine, 1985, 312, 995–96.Google ScholarPubMed
28.Kasper, J. A., Walden, D. C., & Wilensky, G. R.Who are the uninsured? NMCES Data Preview Series, Number 1. Rockville, MD: National Center for Health Services Research and Health Care Technology Assessment, 1980.Google Scholar
29.Kastiel, D. L.Insurers want controls on transplant costs. Business Insurance, 11 4, 1985.Google Scholar
30.Knox, R. A.Heart transplants: To pay or not to pay. Science, 1980, 209, 570–75.CrossRefGoogle ScholarPubMed
31.Marshall, J. December 28, 1984 memorandum to Assistant Secretary for Health. Subject: the National Heart Transplantation Study: Final Report. Rockville, MD: The National Center for Health Care Services Research and Health Care Technology Assessment, 1984.Google Scholar
32.Medical Transplant Study Commission. Organ transplants in Maryland: issues and recommendations. Baltimore, MD: Maryland Department of Health and Mental Hygiene, 1985.Google Scholar
33.Mundinger, M. O.Health service funding cuts and the declining health of the poor. New England Journal of Medicine, 1985, 313, 44–47.CrossRefGoogle ScholarPubMed
34.Newman, H.Exclusion of heart transplantation procedures from Medicare coverage. Federal Register. 1980, 45, 52296–97.Google Scholar
35.Newman, H. N.Health Care Financing Administration, Medicare program: Solicitation of hospitals and medical centers to participate in a study of heart transplants. Federal Register, 1981, 46, 7072–75.Google Scholar
36.Office of Technology Assessment. Medical technology and the costs of the Medicare program. Report No. OTA-H-227. Washington, DC: U.S. Government Printing Office, 1984.Google Scholar
37.Office of Health Technology Assessment. Public health service assessment of liver transplantation, 1983. Rockville, MD: National Center for Health Services Research and Health Care Technology Assessment, 1983.Google Scholar
38.Reiss, J. B., Burckhardt, J., & Hellinger, F. Cost and regulation of new medical technologies: Heart transplants as a case study. In McNeil, B. J. & Cravalho, E. G. (eds.), Critical Issues in Medical Technology. Boston, MA: Auburn House Publishing, 1982, 399–417.Google Scholar
39.President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. Securing access to health care: volume one: report. Washington, DC: U.S. Government Printing Office, 1983.Google Scholar
40.Robert Wood Johnson Foundation. Special Report: updated report on access to health care for the American people. New Jersey: Robert Wood Johnson Foundation, 1983.Google Scholar
41.Report of the Massachusetts Task Force on Organ Transplantation. Law, Medicine, and Health Care, 1985, 13, 8–26.CrossRefGoogle Scholar
42.Ruby, G., Banta, H. D., & Kesselman-Burns, A.Medicare coverage, medicare costs, and medical technology. Journal of Health Politics, Policy and Law, 1985, 10, 141–55.CrossRefGoogle ScholarPubMed
43. Personal communication from Ralph W. Schaffarzick, M.D.Google Scholar
44.Scheaffer, L. D. Role of the HCFA in the regulation of new medical technologies. In McNeil, B. J. & Cravalho, E. G. (eds.), Critical issues in medical technology. Boston, MA: Auburn House Publishing, 1982.Google Scholar
45.Swartz, K.The changing face of the uninsured. Presentation at the National Conference of the Association of Health Services Research, 1984.Google Scholar
46.Task Force on Organ Transplantation. Report to the Secretary and the Congress on immunosuppressive therapies. Rockville, MD: Office of Organ Transplantation, 1985.Google Scholar
47.Technology Evaluation and Coverage. Criteria for evaluating institutions for liver and heart transplants. Chicago, IL: Health Benefits Management Division, Blue Cross and Blue Shield, 1985.Google Scholar
48.Thurow, L. C.Medicine versus economics. New England Journal of Medicine, 1985, 313, 611–14.CrossRefGoogle ScholarPubMed
49.United Hospital Fund of New York. Hospitals and the uninsured poor: measuring and paying for uncompensated care. New York, NY: United Hospital Fund/Publications Program, 1985.Google Scholar
50.Wilensky, G. R. & Berk, M. L. The poor, sick, uninsured, and the role of Medicaid. In United Hospital Fund, Hospitals and the uninsured poor. New York, NY: United Hospital Fund of New York, 1985.Google Scholar